Biobot Surgical Pte Ltd is a Singapore-based company founded in 2007. We strive to be the global technology leader in minimally invasive robotic solutions. We use our technology to improve the accuracy of diagnosis and treatment of patients. We develop state-of-the-art solutions to improve clinical outcomes and therefore improve quality of life. Biobot Surgical Pte Ltd has been part of ZIG Venture since 2011.
To ensure success, a talent team has been assembled in robotic design and technology, medical imaging, software development and clinical applications.
To date, the iSR'obot Mona Lisa has received key regulatory approvals including Europe (CE mark), USA (US FDA), Australia (TGA) and Singapore (HSA), and is used in some of the most prestigious hospitals around the world.
Striving to become the gold standard in the diagnosis and prognosis of prostate cancer, the Mona Lisa system is an evolutionary solution and a state-of-the-art next generation development.